Director TitleAgeSince
Director/Board Member - 2010-09-30
Director/Board Member - 2010-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
+1.81%+1.60%+13.40%+84.45% 47.15B
-2.54%+3.72%+65.71%+113.61% 37.94B
+0.15%+0.28%-3.35%+45.56% 12.35B
+3.71%+1.72%+14.13%+97.20% 11.52B
+2.23%-1.72%+32.73%+121.98% 8.93B
-0.17%-1.39%+18.30%+44.36% 7.14B
+0.71%+1.75%+53.59%-7.09% 7.02B
+0.68%+1.12%+23.97%+235.28% 6.51B
+6.55%+16.24%-23.92%+16.83% 5.98B
Average +17,991.31%+3.75%+21.62%+83.58% 16.06B
Weighted average by Cap. +0.91%+3.13%+28.08%+89.69%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock